tiprankstipranks

Katherine Bach Kalin Insider Profile

11 Followers
Katherine Bach Kalin, Director at SELLAS Life Sciences Group, holds 154.40K shares in SELLAS Life Sciences Group (Ticker: SLS), holds ― shares in Athersys (Ticker: ATHXQ).
tipranks
Katherine Bach Kalin

Katherine Bach Kalin
SELLAS Life Sciences Group (SLS)
Director

Ranked #6,063 out of 108,921 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+571.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Katherine Bach Kalin's holdings

Insider Roles

SELLAS Life Sciences Group
(SLS)
Director
Athersys
(ATHXQ)
Director
Roles that Katherine Bach Kalin holds in companies

Most Profitable Insider Trade

Stock:
SELLAS Life Sciences Group
(SLS)
Rating:Informative Buy
Date:Nov 21, 2025 - Today
Return:+800.00%
The most profitable trade made by Katherine Bach Kalin

Katherine Bach Kalin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SELLAS Life Sciences Group
Jan 09, 2026
Director
Uninformative Buy
$1.78M
Athersys
Director
List of latest transactions for each holding click on a transaction to see Katherine Bach Kalin's performance on stock

Katherine Bach Kalin insider profile FAQ

What is the percentage of profitable transactions made by Katherine Bach Kalin?
The percentage of profitable transactions made by Katherine Bach Kalin is 100%.
    What is the average return per transaction made by Katherine Bach Kalin?
    The average return per transaction made by Katherine Bach Kalin is 571.00%.
      What stocks does Katherine Bach Kalin hold?
      Katherine Bach Kalin holds: SLS, ATHXQ stocks.
        What was Katherine Bach Kalin’s latest transaction?
        Katherine Bach Kalin latest transaction was an Uninformative Buy of ―.
          What was Katherine Bach Kalin's most profitable transaction?
          Katherine Bach Kalin’s most profitable transaction was an Informative Buy of SLS stock on November 21, 2025. The return on the trade was 800.00%.
            What is Katherine Bach Kalin's role in SELLAS Life Sciences Group?
            Katherine Bach Kalin's role in SELLAS Life Sciences Group is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.